Drug-resistant infections are responsible for an increasing number of treatment failures, increased mortality and decreased food productivity. Inappropriate use, poor adherence to prescriptions, and overuse of antibiotics are main drivers of antimicrobial resistance (AMR) and have a detrimental impact on the effectiveness of these critical medicines.
This first Call of the European Partnership on One Health Antimicrobial Resistance (OHAMR) aims to improve the treatment success rates of the patients/animals/plants affected by bacterial or fungal infections by providing new treatment options while reducing the risk of resistance in the different One Health settings.
Research & innovation proposals submitted under this call must address one of the following topics:
- Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance.
- Develop tools and methods to improve adherence to treatment protocols.
- Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use.
The call, with a total budget of over 31 million Euro, is supported by 37 funding organisations from 28 different countries: Austria, Belgium, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkiye and United Kingdom. The funding will be provided by the national/regional research funding organisations participating in the call. Each of them will fund their national/regional applicants, according to their own eligibility rules.
For Germany the Bundesministerium für Forschung, Technologie und Raumfahrt (BMFTR) and Deutsches Zentrum für Luft- und Raumfahrt Projektträger (DLR-PT) participate in the call.
The call will only support transnational research and innovation projects:
- The consortium must include a minimum of three (3) eligible partners asking for funding from three different eligible countries (including at least two amongst EU Member States or Associated Countries).
- The consortium can include a maximum of six (6) project partners, including non-funded partners.
- The maximum number of partners can be increased to seven (7) if the consortium includes: at least one partner from an under-represented country (For the purpose of this call, the under-represented countries are: Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Moldova, Poland, and Slovakia) or at least one partner where the Principal Investigator meets the definition of an Early-Career Researcher or a start-up, SME, or an Industry.
A match-making tool has been created for applicants, to facilitate networking and the creation of consortia.
OHAMR invites researchers to a live webinar on 26 November presenting the first joint transnational call and the partner search tool.
